CFG
ATRS

Citizens Financial Group’s Antares Pharma, Inc. ATRS Stock Holding History

Citizens Financial Group’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,742
Closed -$5K – 1033
2020
Q2 		$5K Hold
1,742
– – ﹤0.01% 902
2020
Q1 		$4K Hold
1,742
– – ﹤0.01% 920
2019
Q4 		$8K Buy
+1,742
New +$7.13K ﹤0.01% 801

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Citizens Financial Group's ATRS Position: Q3 2020 in Review

Citizens Financial Group sold out of Antares Pharma, Inc. (ATRS) in Q3 2020, closing a stake of 1,742 shares — an estimated $5K sold.

Citizens Financial Group first reported a position in ATRS in Q4 2019 and held it in 3 quarters. The position peaked at $8K in Q4 2019. 164 funds tracked by Wall St. Rank hold ATRS as of Q3 2020.

  • Citizens Financial Group reported no remaining Antares Pharma, Inc. position as of Q3 2020 after selling out during the quarter.
  • Citizens Financial Group sold 1,742 Antares Pharma, Inc. shares in Q3 2020, an estimated $5K.
  • Citizens Financial Group first reported a position in Antares Pharma, Inc. in Q4 2019 and held it in 3 quarters.
  • Citizens Financial Group's Antares Pharma, Inc. position peaked at $8K in Q4 2019.
  • 164 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q3 2020.

Based on Citizens Financial Group's 13F filing for Q3 2020, filed 12 Nov 2020.